Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
19.32B
Market cap19.32B
Price-Earnings ratio
25.68
Price-Earnings ratio25.68
Dividend yield
0.95%
Dividend yield0.95%
Average volume
2.85M
Average volume2.85M
High today
$104.28
High today$104.28
Low today
$101.45
Low today$101.45
Open price
$102.18
Open price$102.18
Volume
3.36M
Volume3.36M
52 Week high
$112.55
52 Week high$112.55
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

With a market cap of 19.32B, Zimmer Biomet(ZBH) trades at $102.03. The stock has a price-to-earnings ratio of 25.68 and currently yields dividends of 0.95%.

As of 2026-11-17, Zimmer Biomet(ZBH) stock has fluctuated between $101.45 and $104.28. The current price stands at $102.03, placing the stock +0.6% above today's low and -2.2% off the high.

The Zimmer Biomet(ZBH)'s current trading volume is 3.36M, compared to an average daily volume of 2.85M.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $112.55 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $112.55 at its peak.

ZBH News

Seeking Alpha 9h
Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robot

Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robot Nov 17, 2026, 12:05 PM ET Zimmer Biomet Holdings, Inc. (ZBH) Stock By : Dulan Lokuwithana, SA...

Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robot
Investing.com 9h
Why is Zimmer Biomet stock climbing today? - Investing.com

...

Why is Zimmer Biomet stock climbing today? - Investing.com
TipRanks 14h
Zimmer Biomet upgraded to Overweight from Equal Weight at Wells Fargo

Wells Fargo upgraded Zimmer Biomet (ZBH) to Overweight from Equal Weight with a price target of $123, up from $113. The firm says Monogram should lift Zimmer’s...

Analyst ratings

66%

of 29 ratings
Buy
31%
Hold
65.5%
Sell
3.4%

More ZBH News

TipRanks 2d
Zimmer Biomet price target lowered to $101 from $102 at BMO Capital

BMO Capital lowered the firm’s price target on Zimmer Biomet (ZBH) to $101 from $102 and keeps a Market Perform rating on the shares. The firm is adjusting its...

TipRanks 5d
Zimmer Biomet Issues $1 Billion in Senior Notes

Zimmer Biomet Holdings ( (ZBH) ) has provided an update. On November 5, 2026, Zimmer Biomet Holdings entered underwriting agreements for €500.0 million of 4.37...

Simply Wall St 6d
How Investors May Respond To Zimmer Biomet Stock Surgeon Guided Autonomy Launch

Zimmer Biomet Holdings introduced its Surgeon-Guided Autonomy vision for intelligent orthopedic surgery and reported Q3 2026 results with US$2,062.9 million in...

How Investors May Respond To Zimmer Biomet Stock Surgeon Guided Autonomy Launch

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.